3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Multiple Myeloma
3
Mucositis
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Febrile Neutropenia
2
Polycystic Ovary Syndrome
1
Neurotoxicity Syndromes
1
Neoplasms, Plasma Cell
1
Lymphoma, Non-Hodgkin
1
Inflammation
1
Hematologic Neoplasms
1
Early Stage Triple Negative ER Low Breast Cancer
1
Disease Progression
1
Cytokine Release Syndrome
1
Colorectal Neoplasms
1
Burkitt Lymphoma
1
Arthritis, Rheumatoid
1
Interventions
epigallocatechin gallate
2
XENP 1595
2
Etanercept
2
Ascorbic Acid
2
salicylsalicylic acid
1
microcrystalline cellulose
1
ginger extract
1
dapagliflozin
1
cytisine
1
Tablets
1
Sulindac
1
Spirometry
1
Specimen Handling
1
Sodium Salicylate
1
Radiotherapy, Conformal
1
Pregabalin
1
Omeprazole
1
Losartan
1
Ketorolac
1
Interleukin 1 Receptor Antagonist Protein
1
Infliximab
1
Hematologic Tests
1
Diet Therapy
1
Atorvastatin
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Inflammation
×
Interleukin 1 Receptor Antagonist Protein
×
Clear all
NCT00537667
2009-11-26
The SPECTRA Study
Swedish Orphan Biovitrum
Phase 2
Terminated
22 enrolled